Literature DB >> 1465406

Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis.

B M Mueller1, R A Reisfeld, T S Edgington, W Ruf.   

Abstract

Metastasis is a multistep process which requires highly adapted interactions of tumor cells with host target organs. Compared with nonmetastatic cells, metastatic human melanoma cells express 1000-fold higher level of tissue factor (TF), the major cellular initiator of the plasma coagulation protease cascades. To explore whether TF may contribute to metastatic tumor dissemination, we analyzed the effect of specific inhibition of TF function on human melanoma metastasis in severe combined immunodeficient (SCID) mice. Using species-specific antibodies to TF, we demonstrate that initial adherence in insufficient for successful tumor cell implantation in a target organ. Rapid arrest of human tumor cells in the lungs of mice was not diminished by inhibition of TF. However, inhibition of TF receptor function and consequent reduction in local protease generation abolished prolonged adherence of tumor cells, resulting in significantly reduced numbers of tumor cells retained in the vasculature of the lungs. The growth of pulmonary metastases was also significantly inhibited by a blocking anti-TF monoclonal antibody and Fab fragments thereof, whereas a noninhibitory antibody lacked antimetastatic effects. Cell surface expression of functional TF thus contributes to melanoma progression by allowing metastatic cells to provide requisite signals for prolonged adhesive interactions and/or transmigration of tumor cells across the endothelium, resulting in successful metastatic tumor implantation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1465406      PMCID: PMC50651          DOI: 10.1073/pnas.89.24.11832

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  48 in total

Review 1.  Endothelial cell interactions with granulocytes: tethering and signaling molecules.

Authors:  G A Zimmerman; S M Prescott; T M McIntyre
Journal:  Immunol Today       Date:  1992-03

Review 2.  Integrins: versatility, modulation, and signaling in cell adhesion.

Authors:  R O Hynes
Journal:  Cell       Date:  1992-04-03       Impact factor: 41.582

Review 3.  Why do cancer cells metastasize into particular organs?

Authors:  D Rusciano; M M Burger
Journal:  Bioessays       Date:  1992-03       Impact factor: 4.345

4.  Role of fibrin coagulation in protection of murine tumor cells from destruction by cytotoxic cells.

Authors:  Y Gunji; E Gorelik
Journal:  Cancer Res       Date:  1988-09-15       Impact factor: 12.701

5.  Influence of tumor-derived interleukin 1 on melanoma-endothelial cell interactions in vitro.

Authors:  F J Burrows; D O Haskard; I R Hart; J F Marshall; S Selkirk; S Poole; P E Thorpe
Journal:  Cancer Res       Date:  1991-09-15       Impact factor: 12.701

6.  Cell membrane signaling as target in cancer therapy. II: Inhibitory effect of N,N,N-trimethylsphingosine on metastatic potential of murine B16 melanoma cell line through blocking of tumor cell-dependent platelet aggregation.

Authors:  H Okoshi; S Hakomori; M Nisar; Q H Zhou; S Kimura; K Tashiro; Y Igarashi
Journal:  Cancer Res       Date:  1991-11-15       Impact factor: 12.701

7.  Granule membrane protein 140 (GMP140) binds to carcinomas and carcinoma-derived cell lines.

Authors:  A Aruffo; M T Dietsch; H Wan; K E Hellström; I Hellström
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

8.  Tissue factor activity of normal and neoplastic cells: quantitation and species specificity.

Authors:  J L Kadish; K M Wenc; H F Dvorak
Journal:  J Natl Cancer Inst       Date:  1983-03       Impact factor: 13.506

Review 9.  Rationale and experimental design for the VA Cooperative Study of Anticoagulation (Warfarin) in the Treatment of Cancer.

Authors:  L R Zacharski; W G Henderson; F R Rickles; W B Forman; C J Cornell; R J Forcier; H W Harrower; R O Johnson
Journal:  Cancer       Date:  1979-08       Impact factor: 6.860

10.  The cytoplasmic domain of tissue factor is phosphorylated by a protein kinase C-dependent mechanism.

Authors:  T F Zioncheck; S Roy; G A Vehar
Journal:  J Biol Chem       Date:  1992-02-25       Impact factor: 5.157

View more
  92 in total

1.  Fatal embryonic bleeding events in mice lacking tissue factor, the cell-associated initiator of blood coagulation.

Authors:  T H Bugge; Q Xiao; K W Kombrinck; M J Flick; K Holmbäck; M J Danton; M C Colbert; D P Witte; K Fujikawa; E W Davie; J L Degen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

2.  Inhibition of tissue factor by ixolaris reduces primary tumor growth and experimental metastasis in a murine model of melanoma.

Authors:  Andreia Da Silva de Oliveira; Luize G Lima; Andréa Mariano-Oliveira; Daniel E Machado; Luiz E Nasciutti; John F Andersen; Lars C Petersen; Ivo M B Francischetti; Robson Q Monteiro
Journal:  Thromb Res       Date:  2012-06-09       Impact factor: 3.944

3.  Role of tissue factor pathway inhibitor-2 (TFPI-2) in amelanotic melanoma (C-32) invasion.

Authors:  S D Konduri; A Tasiou; N Chandrasekar; G L Nicolson; J S Rao
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

4.  Tissue factor-factor VIIa complex triggers protease activated receptor 2-dependent growth factor release and migration in ovarian cancer.

Authors:  Alice Chanakira; Pamela R Westmark; Irene M Ong; John P Sheehan
Journal:  Gynecol Oncol       Date:  2017-01-29       Impact factor: 5.482

Review 5.  Tissue factor and PAR2 signaling in the tumor microenvironment.

Authors:  Florence Schaffner; Wolfram Ruf
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-08-06       Impact factor: 8.311

6.  Neutrophil activation by the tissue factor/Factor VIIa/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome.

Authors:  Patricia Redecha; Claus-Werner Franzke; Wolfram Ruf; Nigel Mackman; Guillermina Girardi
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

7.  Tissue factor regulation by epidermal growth factor receptor and epithelial-to-mesenchymal transitions: effect on tumor initiation and angiogenesis.

Authors:  Chloe C Milsom; Joanne L Yu; Nigel Mackman; Johann Micallef; G Mark Anderson; Abhijit Guha; Janusz W Rak
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

8.  Inhibition of osteolytic bone metastasis by unfractionated heparin.

Authors:  Colin K Yee; Martin Butcher; Melec Zeadin; Jeffrey I Weitz; Stephen G Shaughnessy
Journal:  Clin Exp Metastasis       Date:  2008-09-24       Impact factor: 5.150

9.  Cross-talk of integrin alpha3beta1 and tissue factor in cell migration.

Authors:  Andrea Dorfleutner; Edith Hintermann; Takehiko Tarui; Yoshikazu Takada; Wolfram Ruf
Journal:  Mol Biol Cell       Date:  2004-07-14       Impact factor: 4.138

10.  Tissue factor-factor VIIa-specific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration.

Authors:  Gertrud M Hjortoe; Lars C Petersen; Tatjana Albrektsen; Brit B Sorensen; Peder L Norby; Samir K Mandal; Usha R Pendurthi; L Vijaya Mohan Rao
Journal:  Blood       Date:  2004-01-08       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.